MATINAS BIOPHARMA HOLDINGS, INC. Loss Contingency, Damages Sought, Value
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Loss Contingency, Damages Sought, Value of $205.00 thousand for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LossContingencyDamagesSoughtValue · last filed 2026-05-08
| Period end | Loss Contingency, Damages Sought, Value 12 month |
|---|---|
| 2025-12-31 | $205.00K 10-Q · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |